Efficacy of Tocilizumab in Modifying the Inflammatory Parameters of Patients With COVID-19 (COVITOZ-01)
Clinical trial NCT04435717 · TERMINATED
Trial details
- NCT number
- NCT04435717
- Sponsor
- Hospital Universitario Ramon y Cajal
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-04
- Primary completion
- 2020-11-04
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.